Many of our current shareholders have many questions as to what AngioSoma, Inc. is doing, so we are making a shareholder presentation available (the PDF version available here) to all of our shareholders. We intend to update this as we progress in our business plan. © 2016 by AngioSoma, Inc., all rights reserved.
Montgomery, Texas (September 21, 2016) – AngioSoma, Inc. (the ‘Company‘, ‘we‘, and ‘our‘), announces the formation of the Soma Nutraceuticals, Inc. subsidiary for the acquisition and marketing of proven nutraceutical products, as well as acquisition discussions with multiple proven nutraceutical intellectual properties. Our Chairman Emeritus “Doc” Summers owns some of the proven nutraceutical products we Read more about AngioSoma, Inc. enters discussions with Nutraceutical Intellectual Property Owners[…]
As a publicly traded organization, AngioSoma, Inc. is an SEC reporting company, which requires the company to follow the mandates of Regulation Fair Disclosure (also known as “Regulation FD” or “Reg FD“). Regulation FD requires public companies to “disclosure material information to all investors at the same time.” To that extent, AngioSoma, Inc. provides all Read more about What type of news is provided by the company on Twitter?[…]